TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase

Contributed by: Business Wire

Tags

Research

Infectious Diseases

FDA

Genetics

Biotechnology

Other Health

Health

Pharmaceutical

Science

TriLink BioTechnologies

More Like This

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research

PR Newswire associated0

Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis

PR Newswire associated0

Zymo Research Unveils PureRec DSN: The Most Selective Duplex-Specific Nuclease

PR Newswire associated0

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia